Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Architecture of cannabinoid signaling in mouse retina.

The Journal of comparative neurology | 2010

Cannabinoid receptors and their ligands constitute an endogenous signaling system that is found throughout the body, including the eye. This system can be activated by Delta(9)-tetrahydrocannabinol, a major drug of abuse. Cannabinoids offer considerable therapeutic potential in modulating ocular immune and inflammatory responses and in regulating intraocular pressure. The location of cannabinoid receptor 1 (CB(1)) in the retina is known, but recently a constellation of proteins has been identified that produce and break down endocannabinoids (eCBs) and modulate CB(1) function. Localization of these proteins is critical to defining specific cannabinoid signaling circuitry in the retina. Here we show the localization of diacylglycerol lipase-alpha and -beta (DGLalpha/beta), implicated in the production of the eCB 2-arachidonoyl glycerol (2-AG); monoacylglycerol lipase (MGL) and alpha/beta-hydrolase domain 6 (ABHD6), both implicated in the breakdown of 2-AG; cannabinoid receptor-interacting protein 1a (CRIP1a), a protein that may modulate CB(1) function; and fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), which have been shown to break down the eCB anandamide and related acyl amides. Our most prominent finding was that DGLalpha is present in postsynaptic type 1 OFF cone bipolar cells juxtaposed to CB(1)-containing cone photoreceptor terminals. CRIP1a is reliably presynaptic to DGLalpha, consistent with a possible role in cannabinoid signaling, and NAAA is restricted to retinal pigment epithelium, whereas DGLbeta is limited to retinal blood vessels. These results taken together with previous anatomical and functional studies define specific cannabinoid circuitry likely to modulate eCB signaling at the first synapse of the retina as well as in the inner plexiform layer.

Pubmed ID: 20653038 RIS Download

Associated grants

  • Agency: NIDA NIH HHS, United States
    Id: DA024122
  • Agency: NIDA NIH HHS, United States
    Id: R21 DA024122
  • Agency: NIDA NIH HHS, United States
    Id: R21 DA024122-02
  • Agency: NIDA NIH HHS, United States
    Id: DA11322
  • Agency: NIDA NIH HHS, United States
    Id: DA021696
  • Agency: NIDA NIH HHS, United States
    Id: K05 DA021696
  • Agency: NIDA NIH HHS, United States
    Id: R21 DA024122-01
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA011322

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Recoverin (antibody)

RRID:AB_2253622

This polyclonal targets Rcvrn

View all literature mentions

FAAH (antibody)

RRID:AB_2314389

This unknown targets

View all literature mentions

G_13 (antibody)

RRID:AB_2314436

This unknown targets

View all literature mentions

hCRIP1a (antibody)

RRID:AB_2314633

This unknown targets

View all literature mentions

mABHD6 (antibody)

RRID:AB_2314757

This unknown targets

View all literature mentions

mMGL (antibody)

RRID:AB_2314805

This unknown targets

View all literature mentions

rCB1-CT (antibody)

RRID:AB_2315249

This unknown targets

View all literature mentions

rCB1-L15 (antibody)

RRID:AB_2315250

This unknown targets

View all literature mentions

rDGL alpha (antibody)

RRID:AB_2315251

This unknown targets

View all literature mentions

rDGL beta (antibody)

RRID:AB_2315252

This unknown targets

View all literature mentions

rNAAA (antibody)

RRID:AB_2315288

This unknown targets

View all literature mentions

Monoclonal Anti-Calbindin-D-28K antibody produced in mouse (antibody)

RRID:AB_476894

This monoclonal targets Calbindin-D-28K antibody produced in mouse

View all literature mentions

SV2 (antibody)

RRID:AB_2315387

This unknown targets

View all literature mentions

PSD95 antibody [7E3-1B8] (antibody)

RRID:AB_625474

This monoclonal targets PSD95 antibody [7E3-1B8]

View all literature mentions